eCiphrNeuro
Assessment of Neuronal Activity Using Microelectrode Array. The eCiphrNeuro assay uses primary cultures of rat cortical neurons. Cyprotex’s neuronal assay uses high throughput microelectrode arra...
Cyprotex Discovery Ltd
Cyprotex is a specialist provider of experimental and computational ADME services to support ADME/toxicity and pharmacokinetics assessment for drug discovery partners.
Cloe® Screen
In vitro ADME screening service Our in vitro ADME screening service offers a portfolio of assays for investigating: in vitro metabolism, in vitro permeability, solubility & physicochemical properties,...
Cloe® Select
Bespoke ADME and DMPK experimental service Our Cloe® Select ADME and DMPK experimental service is designed to meet the requirements of later stage studies. Services include: in vitro metabolism, in vi...
Cloe® Predict
Cloe® PK - Pharmacokinetic prediction using PBPK modelling Cloe® PK is an innovative software system that uses PBPK modelling for pharmacokinetic prediction. By integrating physicochemical and ADME sc...
Browse Products by Field
Cyprotex is a specialist provider of experimental and computational ADME services to support ADME/toxicity and pharmacokinetics assessment for drug discovery partners.
Our core capabilities include Cloe Screen in vitro ADME screening assays, and Cloe PK - a pharmacokinetic prediction system which integrates core ADME and physicochemical compound data to predict compound levels in plasma and major organs in the body. This unique combination of technologies is aimed at improving pharmaceutical productivity by improving the quality of compound libraries and drug candidates progressing through the drug pipeline.